Relay Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 11/14/2024 | 27.90 M | $197.57 M | 0.00% | 19.90% |
VANGUARD GROUP INC | 11/13/2024 | 14.46 M | $102.40 M | 23.57% | 10.31% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 11.74 M | $83.13 M | 100.00% | 8.37% |
CASDIN CAPITAL, LLC | 11/14/2024 | 9.25 M | $65.50 M | 9.50% | 6.60% |
BELLEVUE GROUP AG | 11/14/2024 | 7.38 M | $52.23 M | 15.68% | 5.26% |
JPMORGAN CHASE & CO | 11/08/2024 | 5.52 M | $39.06 M | 39.21% | 3.93% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 5.28 M | $37.39 M | 4.79% | 3.77% |
STATE STREET CORP | 11/14/2024 | 4.30 M | $30.45 M | 1.22% | 3.07% |
NEXTECH INVEST LTD. | 11/14/2024 | 3.85 M | $27.23 M | 0.00% | 2.74% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 3.57 M | $25.26 M | 100.00% | 2.54% |
BRAIDWELL LP | 11/14/2024 | 3.50 M | $24.78 M | 16.38% | 2.50% |
CITADEL ADVISORS LLC | 11/14/2024 | 2.91 M | $20.60 M | 150.09% | 2.07% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.73 M | $19.35 M | 15.54% | 1.95% |
EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 2.68 M | $18.99 M | 100.00% | 1.91% |
ECOR1 CAPITAL, LLC | 11/14/2024 | 2.50 M | $17.70 M | 100.00% | 1.78% |
BIOIMPACT CAPITAL LLC | 11/13/2024 | 2.03 M | $14.39 M | 59.52% | 1.45% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.98 M | $13.99 M | 33.07% | 1.41% |
WALLEYE CAPITAL LLC | 11/14/2024 | 1.82 M | $12.89 M | 6,659.20% | 1.30% |
BOXER CAPITAL, LLC | 11/14/2024 | 1.82 M | $12.88 M | 0.00% | 1.30% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.75 M | $12.38 M | 15.02% | 1.25% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.65 M | $11.68 M | 100.00% | 1.18% |
FINEPOINT CAPITAL LP | 11/13/2024 | 1.63 M | $11.51 M | 1.30% | 1.16% |
ALPHABET INC. | 11/08/2024 | 1.57 M | $11.11 M | 0.00% | 1.12% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2024 | 1.54 M | $10.92 M | 100.00% | 1.10% |
MARSHALL WACE, LLP | 11/14/2024 | 1.41 M | $9.95 M | 408.02% | 1.00% |
FRANKLIN RESOURCES INC | 11/27/2024 | 1.40 M | $9.43 M | 3,883.81% | 1.00% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 1.35 M | $9.55 M | 100.00% | 0.96% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.25 M | $8.86 M | 57.30% | 0.89% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 1.23 M | $8.71 M | 3.29% | 0.88% |
FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 1.23 M | $8.68 M | 100.00% | 0.87% |
BAKER BROS. ADVISORS LP | 11/14/2024 | 1.16 M | $8.21 M | 0.00% | 0.83% |
CANDRIAM S.C.A. | 11/13/2024 | 1.09 M | $7.74 M | 55.34% | 0.78% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.06 M | $7.50 M | -7.79% | 0.76% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.04 M | $7.33 M | 26.10% | 0.74% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 1.02 M | $7.19 M | 39.11% | 0.72% |
FORESITE CAPITAL MANAGEMENT IV, LLC | 11/14/2024 | 1.00 M | $7.08 M | 100.00% | 0.71% |
MORGAN STANLEY | 11/14/2024 | 962,111 | $6.81 M | -22.55% | 0.69% |
SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 945,839 | $6.70 M | 100.00% | 0.67% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 910,000 | $6.44 M | 100.00% | 0.65% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 693,350 | $4.91 M | 100.00% | 0.49% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 671,095 | $4.75 M | -26.18% | 0.48% |
ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 626,058 | $4.43 M | 100.00% | 0.45% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 614,200 | $4.35 M | 44.59% | 0.44% |
BESSEMER GROUP INC | 11/12/2024 | 584,633 | $4.14 M | 0.03% | 0.42% |
ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 541,124 | $3.83 M | 0.00% | 0.39% |
ALGERT GLOBAL LLC | 11/12/2024 | 513,277 | $3.63 M | 7.63% | 0.37% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 460,000 | $3.26 M | 100.00% | 0.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 419,242 | $2.97 M | 100.00% | 0.30% |
EXOME ASSET MANAGEMENT LLC | 12/13/2024 | 414,629 | $2.94 M | 100.00% | 0.30% |
TREXQUANT INVESTMENT LP | 11/12/2024 | 411,862 | $2.92 M | 123.09% | 0.29% |
Relay Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 223 institutional investors and hedge funds held shares of Relay Therapeutics, Inc.. The most heavily invested institutionals were:
SB INVESTMENT ADVISERS (UK) LTD: 27.9 M
VANGUARD GROUP INC: 14.46 M
BlackRock Funding, Inc. /DE: 11.74 M
Casdin Capital, LLC: 9.25 M
Bellevue Group AG: 7.38 M
JPMORGAN CHASE & CO: 5.52 M
112.32% of Relay Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 170.11 M shares in the last 24 months. This purchase volume represents approximately $728.08 M in transactions.